| (Values in U.S. Thousands) | Aug, 2026 | Aug, 2026 | Aug, 2026 | Aug, 2026 | Aug, 2026 |
| Sales | 0 | 0 | 0 | 0 | 0 |
| Sales Growth | unch | unch | unch | unch | unch |
| Net Income | 0 | 0 | 0 | 0 | 0 |
| Net Income Growth | unch | unch | unch | unch | unch |
Terumo Corp (TRUMF)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Terumo Corp was incorporated in Japan on September 17, 1921. The Company is engaged in manufacturing and selling of medical products and equipment, including pharmaceuticals, nutritional food supplement, blood bags, disposable medical devices, cardiovascular systems, vascular grafts, peritoneal dialysis, blood glucose monitoring system, medical electronic, and digital thermometers. The Company operates in business segments including Cardiac & Vascular Business, Blood Management Business, and General Hospital Business. The Cardiac & Vascular Business offers products for vascular interventional treatment including interventional systems for treatment of coronary artery disease & cardiovascular systems for cardiac surgery. The Blood Management Business provides processing management system, including blood bags, leukocyte reduction filters and other equipment's. The General Hospital Business provides products that are used in hospitals on a daily basis include syringes and IV solution products, as well as products that are used by patients at home. The Company geographical segment includes Japan, Europe, Americas, Asia and others.